Tag: RPE65 Mutation Therapy
Luxturna (Voretigene Neparvovec) FDA-Approved Gene Therapy Targeting RPE65 Mutations in Retinitis...
Have you ever imagined a world where genetic eye diseases can be treated at their source, rather than just managed over time? Thanks to...
